Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Alnylam PharmaceuticalsAlnylam Pharmaceuticals
VS
GenentechGenentech
Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

675 W Kendall St, Cambridge, 02142, US

Last Update: 04/04/2026

View Profile
Between 800 and 849
http://www.alnylam.com
807/1000Good

SILENCE DISEASE. AMPLIFY LIFE.™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:2,711
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Genentech

Genentech

1 Dna Way, South San Francisco, California, US, 94080

Last Update: 11/09/2026

View Profile
Between 750 and 799
http://www.gene.com
794/1000Fair

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a differe...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:18,082
Subsidiaries:50
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Genentech

Genentech

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Alnylam Pharmaceuticals in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Genentech in 2026.

Incidents

Incident History - Alnylam Pharmaceuticals (X = Date, Y = Severity)

Alnylam Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Genentech (X = Date, Y = Severity)

Genentech cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Incidents
No explicit notable incidents reported.
Genentech

Genentech

Incidents
No explicit notable incidents reported.

FAQ

Between Alnylam Pharmaceuticals company and Genentech company, which one has the best AI Cybersecurity Score ?
Between Alnylam Pharmaceuticals company and Genentech company, which one has experienced more cyber incidents in the past ?
Between Alnylam Pharmaceuticals company and Genentech company, which one has experienced more cyber incidents this year ?
Between Alnylam Pharmaceuticals company and Genentech company, which one has experienced at least one ransomware attack ?
Between Alnylam Pharmaceuticals company and Genentech company, which one has experienced at least one data breach ?
Between Alnylam Pharmaceuticals company and Genentech company, which one has experienced at least one targeted cyberattack ?
Between Alnylam Pharmaceuticals company and Genentech company, which one has experienced at least one vulnerability ?
Between Alnylam Pharmaceuticals company and Genentech company, which one holds the most compliance certifications ?
Between Alnylam Pharmaceuticals company and Genentech company, which one holds the fewest compliance certifications ?
Between Alnylam Pharmaceuticals company and Genentech company, which one has the most subsidiaries ?
Between Alnylam Pharmaceuticals company and Genentech company, which one has the largest number of employees ?
Between Alnylam Pharmaceuticals and Genentech, which company holds both SOC 2 Type 1 certifications ?
Between Alnylam Pharmaceuticals and Genentech, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Alnylam Pharmaceuticals or Genentech ?
Which company is PCI DSS compliant - Alnylam Pharmaceuticals or Genentech ?
Between Alnylam Pharmaceuticals and Genentech, which company complies with HIPAA regulations for healthcare data ?
Between Alnylam Pharmaceuticals and Genentech, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-100739
SUMMARY

A vulnerability was detected in mathurvishal CloudClassroom-PHP-Project up to 5dadec098bfbbf3300d60c3494db3fb95b66e7be. This impacts an unknown function of the file viewresult.php. Performing a manipulation of the argument seno results in sql injection. Remote exploitation of the attack is possible. The exploit is now public and may be used. This product follows a rolling release approach for continuous delivery, so version details for affected or updated releases are not provided. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 7.3)
CVSS2
Base Score: 7.5
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
CVSS3
Base Score: 7.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.5
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
3.9
REFERENCES
CVE-2026-94408
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 4.9)
CVSS3
Base Score: 4.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
1.2
REFERENCES
CVE-2026-94400
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-94399
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-94398
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
REFERENCES